Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis

Citations Over TimeTop 10% of 2024 papers

Abstract

The success of checkpoint inhibitors (CPIs) for cancer has been tempered by immune-related adverse effects including colitis. CPI-induced colitis is hallmarked by expansion of resident mucosal IFNγ cytotoxic CD8+ T cells, but how these arise is unclear. Here, we track CPI-bound T cells in intestinal tissue using multimodal single-cell and subcellular spatial transcriptomics (ST). Target occupancy was increased in inflamed tissue, with drug-bound T cells located in distinct microdomains distinguished by specific intercellular signaling and transcriptional gradients. CPI-bound cells were largely CD4+ T cells, including enrichment in CPI-bound peripheral helper, follicular helper, and regulatory T cells. IFNγ CD8+ T cells emerged from both tissue-resident memory (TRM) and peripheral populations, displayed more restricted target occupancy profiles, and co-localized with damaged epithelial microdomains lacking effective regulatory cues. Our multimodal analysis identifies causal pathways and constitutes a resource to inform novel preventive strategies.

Related Papers

• → Transcriptome analysis of human ageing in male skin shows mid-life period of variability and central role of NF-κB(2016)61 cited
• → Antigen‐specific suppression of cytotoxic T cell responses in mice. I. Suppressor T cells are not cytotoxic cells(1978)40 cited
• Orally induced tolerance.(1979)
• The cytotoxic activity of mouse T lymphocytes against allogeneic cytotoxic T cells.(1975)
• → Studying gene expression profiles in specialized brain regions by microSAGE(2000)